These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4040539)

  • 1. [Glycosylated hemoglobin and monitoring of diabetic retinopathy].
    Harada T; Tanabe Y; Kojima K; Harada K
    J Fr Ophtalmol; 1985; 8(4):315-9. PubMed ID: 4040539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylated hemoglobin and diabetic retinopathy.
    Singh R; Prakash V; Shukla PK; Gautam S; Maurya OP
    Ann Ophthalmol; 1991 Aug; 23(8):308-11. PubMed ID: 1952641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes.
    Miralles JM; Corrales JJ; Garcia-Diez LC; Cabezas JA; Reglero A
    Clin Chim Acta; 1982 Jun; 121(3):373-8. PubMed ID: 7105401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rapid glycemic control on progression of diabetic retinopathy.
    Funatsu H; Yamashita H; Ohashi Y; Ishigaki T
    Jpn J Ophthalmol; 1992; 36(3):356-67. PubMed ID: 1464975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control.
    Henricsson M; Nilsson A; Groop L; Heijl A; Janzon L
    Acta Ophthalmol Scand; 1996 Dec; 74(6):523-7. PubMed ID: 9017034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy and hemoglobin A1.
    Nakayoshi N; Nunoi K; Ohnishi Y; Yamana Y; Minei M; Taniguchi Y
    Jpn J Ophthalmol; 1983; 27(1):255-60. PubMed ID: 6855017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the usefulness of HbA1 as an index of control of diabetes: from the viewpoint of progress of diabetic retinopathy.
    Fujita S; Kamado K; Hoshi M
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():403-9. PubMed ID: 6680513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
    Klein R; Myers CE; Lee KE; Paterson AD; Cruickshanks KJ; Tsai MY; Gangnon RE; Klein BE
    JAMA Ophthalmol; 2015 Sep; 133(9):1054-61. PubMed ID: 26181138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of glycosylated hemoglobins and albumins in diabetes mellitus with retinopathy].
    Kammerer L; Jermendy G; Jánosi L; Szelényi J; Brooser G; Koltai M; Pogátsa G
    Z Gesamte Inn Med; 1982 Jul; 37(14):474-7. PubMed ID: 7136093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycosylated hemoglobin and clinical evaluation of the degree of diabetes control. Relation to blood sugar, blood cholesterol, blood triglycerides, and the duration of diabetes and retinopathy. Study of 85 diabetic children and adolescents].
    Dorchy H; Despontin M; Haumont D; Toussaint D; De Vroede M; Loeb H
    Sem Hop; 1982 Dec; 58(47):2773-80. PubMed ID: 6301021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the start of glycemic control on the progression of diabetic retinopathy].
    Funatsu H; Yamashita H; Ohashi Y; Ishigaki T
    Nippon Ganka Gakkai Zasshi; 1991 Mar; 95(3):254-64. PubMed ID: 1872204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between progression of diabetic retinopathy and blood glucose control.
    Funatsu H; Yamashita H; Ohashi Y; Ishigaki T
    Jpn J Ophthalmol; 1991; 35(3):306-16. PubMed ID: 1770671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for the development of diabetic retinopathy in patients with insulin-dependent diabetes mellitus treated with continuous subcutaneous insulin infusion].
    Austenat E
    Wien Med Wochenschr; 1992; 142(13):277-80. PubMed ID: 1413821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum markers of oxidative stress and severity of diabetic retinopathy.
    Hartnett ME; Stratton RD; Browne RW; Rosner BA; Lanham RJ; Armstrong D
    Diabetes Care; 2000 Feb; 23(2):234-40. PubMed ID: 10868837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HbA1 as a parameter of the progression of diabetic retinopathy].
    Brunner H; Schmut O; Faschinger C
    Klin Monbl Augenheilkd; 1982 Nov; 181(5):326-8. PubMed ID: 7162072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric diabetic retinopathy.
    El Hindy N; Ong JM
    J Diabetes; 2010 Jun; 2(2):125-6. PubMed ID: 20923495
    [No Abstract]   [Full Text] [Related]  

  • 18. Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy.
    Losada M; Alio JL
    Doc Ophthalmol; 1996-1997; 93(3):223-9. PubMed ID: 9550350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study.
    Henricsson M; Sellman A; Tyrberg M; Groop L
    Acta Ophthalmol Scand; 1999 Apr; 77(2):218-23. PubMed ID: 10321543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
    Davis MD; Fisher MR; Gangnon RE; Barton F; Aiello LM; Chew EY; Ferris FL; Knatterud GL
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):233-52. PubMed ID: 9477980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.